Search research articles
Contact Us
Filters
Showing results (51-60 of 114) with videos related to
Page
of 12
Sort By:
Schweizerische Medizinische Wochenschrift
|
July 12, 1983
[Reduced dosage of cytosine arabinoside in the treatment of acute myelocytic leukemia. Apropos of 3 cases]
C Andrey, P Beris, C Plancherel, et al.
American Journal of Hematology
|
March 11, 1999
Uterine infiltration as first sign of acute myeloid leukemia
T Matthes, C Collao, K Samii, et al.
Leukemia
|
March 1, 1994
Malignant histiocytosis in the leukaemic stage: a new entity (M5c-AML) in the FAB classification?
F M Laurencet, B Chapuis, P Roux-Lombard, et al.
Blood
|
May 1, 1996
Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts
E Roux, C Helg, F Dumont-Girard, et al.
Blood
|
January 12, 2001
Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation
N Rufer, T H Brümmendorf, B Chapuis, et al.
Blood
|
January 1, 1993
Characterization of mixed chimerism in patients with chronic myeloid leukemia transplanted with T-cell-depleted bone marrow: involvement of different hematologic lineages before and after relapse
E Roux, K Abdi, D Speiser, et al.
Blood
|
September 1, 1996
Donor lymphocyte infusion for a patient with relapsing myelodysplastic syndrome after allogeneic bone marrow transplantation
A Bressoud, B Chapuis, E Roux, et al.
Schweizerische Medizinische Wochenschrift
|
October 26, 1985
[Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody]
B Chapuis, C Helg, P Maurice, et al.
Bone Marrow Transplantation
|
November 25, 1998
Clinical consequences of sensitisation to minor histocompatibility antigens before allogeneic bone marrow transplantation
N Rufer, M Starobinski, B Chapuis, et al.
Schweizerische Medizinische Wochenschrift
|
October 25, 1986
[Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody]
B Chapuis, P Maurice, C Helg, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 114) with videos related to
Sort By:
Page
of 12
Schweizerische Medizinische Wochenschrift
|
July 12, 1983
[Reduced dosage of cytosine arabinoside in the treatment of acute myelocytic leukemia. Apropos of 3 cases]
C Andrey, P Beris, C Plancherel, et al.
American Journal of Hematology
|
March 11, 1999
Uterine infiltration as first sign of acute myeloid leukemia
T Matthes, C Collao, K Samii, et al.
Leukemia
|
March 1, 1994
Malignant histiocytosis in the leukaemic stage: a new entity (M5c-AML) in the FAB classification?
F M Laurencet, B Chapuis, P Roux-Lombard, et al.
Blood
|
May 1, 1996
Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts
E Roux, C Helg, F Dumont-Girard, et al.
Blood
|
January 12, 2001
Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation
N Rufer, T H Brümmendorf, B Chapuis, et al.
Blood
|
January 1, 1993
Characterization of mixed chimerism in patients with chronic myeloid leukemia transplanted with T-cell-depleted bone marrow: involvement of different hematologic lineages before and after relapse
E Roux, K Abdi, D Speiser, et al.
Blood
|
September 1, 1996
Donor lymphocyte infusion for a patient with relapsing myelodysplastic syndrome after allogeneic bone marrow transplantation
A Bressoud, B Chapuis, E Roux, et al.
Schweizerische Medizinische Wochenschrift
|
October 26, 1985
[Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody]
B Chapuis, C Helg, P Maurice, et al.
Bone Marrow Transplantation
|
November 25, 1998
Clinical consequences of sensitisation to minor histocompatibility antigens before allogeneic bone marrow transplantation
N Rufer, M Starobinski, B Chapuis, et al.
Schweizerische Medizinische Wochenschrift
|
October 25, 1986
[Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody]
B Chapuis, P Maurice, C Helg, et al.
Page
of 12